BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11137845)

  • 21. [Decreased plasma soluble P-selectin level in coronary sinus after successful coronary angioplasty in patients with unstable angina].
    Doi N; Nishio K; Nakatani H; Hayashi T; Miyamoto S; Hashimoto T; Dohi K
    J Cardiol; 1999 May; 33(5):251-6. PubMed ID: 10354952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Spencer CG; Gurney D; Blann AD; Beevers DG; Lip GY;
    Hypertension; 2002 Jul; 40(1):61-6. PubMed ID: 12105139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    Am J Hypertens; 2007 Jun; 20(6):699-704. PubMed ID: 17531931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery.
    Hernández-Romero D; Lahoz Á; Roldan V; Jover E; Romero-Aniorte AI; Martinez CM; Jara-Rubio R; Arribas JM; Garcia-Alberola A; Cánovas S; Valdés M; Marín F
    Europace; 2016 Sep; 18(9):1328-34. PubMed ID: 26566941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulation after bioprosthetic aortic valve replacement.
    Nowell J; Jahangiri M
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1201-2; author reply 1202. PubMed ID: 20951265
    [No Abstract]   [Full Text] [Related]  

  • 26. Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis.
    Li-Saw-Hee FL; Blann AD; Goldsmith I; Lip GY
    Am J Cardiol; 1999 Apr; 83(8):1206-9. PubMed ID: 10215285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mid- to long-term outcome comparison of the Medtronic Hancock II and bi-leaflet mechanical aortic valve replacement in patients younger than 60 years of age: a propensity-matched analysis.
    Wang Y; Chen S; Shi J; Li G; Dong N
    Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):280-6. PubMed ID: 26675564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of acute exercise on hemorheological, endothelial, and platelet markers in patients with chronic heart failure in sinus rhythm.
    Gibbs CR; Blann AD; Edmunds E; Watson RD; Lip GY
    Clin Cardiol; 2001 Nov; 24(11):724-9. PubMed ID: 11714130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanical versus bioprosthetic valve replacement in middle-aged patients.
    Kulik A; Bédard P; Lam BK; Rubens FD; Hendry PJ; Masters RG; Mesana TG; Ruel M
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):485-91. PubMed ID: 16857373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.
    Blann AD; Lip GY; Beevers DG; McCollum CN
    Thromb Haemost; 1997 Jun; 77(6):1077-80. PubMed ID: 9241735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis.
    Panzer S; Badr Eslam R; Schneller A; Kaider A; Koren D; Eichelberger B; Rosenhek R; Budde U; Lang IM
    Thromb Haemost; 2010 Feb; 103(2):408-14. PubMed ID: 20024494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of Life and Anxiety in Younger Patients after Biological versus Mechanical Aortic Valve Replacement.
    Kottmaier M; Hettich I; Deutsch MA; Badiu C; Krane M; Lange R; Bleiziffer S
    Thorac Cardiovasc Surg; 2017 Apr; 65(3):198-205. PubMed ID: 27380378
    [No Abstract]   [Full Text] [Related]  

  • 33. von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
    Blackshear JL; McRee CW; Safford RE; Pollak PM; Stark ME; Thomas CS; Rivera CE; Wysokinska EM; Chen D
    JAMA Cardiol; 2016 May; 1(2):198-204. PubMed ID: 27437891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
    Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired Von Willebrand Factor Deficiency at Patient-Prosthesis Mismatch after AVR Procedure-A Narrative Review.
    Grigorescu AE; Anghel A; Buriman DG; Feier H
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement.
    Chan V; Lam BK; Rubens FD; Hendry P; Masters R; Mesana TG; Ruel M
    J Thorac Cardiovasc Surg; 2012 Jul; 144(1):146-51. PubMed ID: 21962842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty.
    Bander J; Elmariah S; Aledort LM; Dlott J; Stelzer P; Halperin JL; Kini AS; Sharma SK
    Thromb Haemost; 2012 Jul; 108(1):86-93. PubMed ID: 22627470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of radiofrequency catheter ablation of atrial fibrillation on soluble P-selectin, von Willebrand factor and IL-6 in the peripheral and cardiac circulation.
    Kornej J; Dinov B; Blann AD; Rolf S; Arya A; Schmidl J; Husser D; Hindricks G; Bollmann A; Lip GY
    PLoS One; 2014; 9(11):e111760. PubMed ID: 25390649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma levels of von Willebrand factor and plasminogen activator in patients with arterial thromboembolism--with special reference to their correlation to the increased catabolism of both fibrinogen and platelets.
    Matsumoto M; Uchiyama T; Kobayashi N; Maekawa T
    Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1105-14. PubMed ID: 2588960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.